Utah Medical Products (UTMD) Capital Expenditures (2010 - 2026)
Utah Medical Products (UTMD) posted quarterly Capital Expenditures of $130000.0 for Q1 2026, down 29.35% year-over-year from $184000.0 in Q1 2025, and up 19.27% quarter-over-quarter from $109000.0 in Q4 2025.
Utah Medical Products (UTMD) Capital Expenditures (2010 - 2026) Analysis & Trends
Utah Medical Products' Capital Expenditures history runs 17 years deep, the most recent figure standing at $130000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 29.35% year-over-year to $130000.0; the TTM figure through Mar 2026 stood at $317000.0 (down 19.13% YoY), while the FY2025 annual figure was $371000.0, up 61.3% from the prior year.
- Capital Expenditures for Q1 2026 stood at $130000.0, up from $109000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $321000.0 in Q3 2022, with the low at $9000.0 in Q4 2024.
- The 5-year median for Capital Expenditures is $109000.0 (2025), against an average of $128176.5.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 2270.0% in 2022, then tumbled 90.0% in 2024.
- Utah Medical Products' Capital Expenditures stood at $38000.0 in 2022, then surged by 136.84% to $90000.0 in 2023, then sank by 90.0% to $9000.0 in 2024, then jumped by 1111.11% to $109000.0 in 2025, then rose by 19.27% to $130000.0 in 2026.
- Business Quant data shows UTMD's Capital Expenditures at $130000.0 in Q1 2026, $109000.0 in Q4 2025, and $27000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Utah Medical Products | 228.77 Mn | 141.24 Mn | 4.76 Mn | 134,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 134,000.00 |
| Jun 30, 2026 | 134,000.00 |
| Mar 31, 2026 | 130,000.00 |
| Mar 31, 2026 | 130,000.00 |
| Dec 31, 2025 | 109,000.00 |
| Dec 31, 2025 | 109,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |